29.19
Tyra Biosciences Inc Borsa (TYRA) Ultime notizie
Tyra Biosciences (NASDAQ:TYRA) Sets New 12-Month HighTime to Buy? - MarketBeat
Wedbush Raises Price Target on Tyra Bioscience to $53 From $37, Keeps Outperform Rating - marketscreener.com
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Can Tyra Biosciences Inc. continue delivering strong returnsTrade Analysis Report & Weekly Stock Performance Updates - mfd.ru
William Blair initiates coverage on Tyra Biosciences stock with Outperform rating - Investing.com Canada
Wedbush Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $37 - 富途牛牛
William Blair Initiates TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $59.62 - 富途牛牛
DKAs Burden The Clinical and Economic Impact - William Blair
Tyra Biosciences stock hits 52-week high, reaching $31.0 By Investing.com - Investing.com South Africa
Tyra Biosciences stock hits 52-week high, reaching $31.0 - Investing.com
Is Tyra Biosciences Inc a turnaround storyWeekly Trading Summary & High Accuracy Trade Signal Alerts - baoquankhu1.vn
AlphaQuest LLC Has $421,000 Holdings in Tyra Biosciences, Inc. $TYRA - MarketBeat
June Brings on Some Huge Insider Buying - AOL.com
(TYRA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Tyra Biosciences Advances BEACH301 Dose Escalation - TipRanks
Tyra Biosciences (TYRA) Price Target Increased by 24.36% to 42.58 - Nasdaq
Resistance Check: Is Tyra Biosciences Inc a strong candidate for buy and holdJuly 2025 Update & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Oppenheimer Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $50 - 富途牛牛
Jefferies Financial Group Forecasts Strong Price Appreciation for Tyra Biosciences (NASDAQ:TYRA) Stock - MarketBeat
Top Growth Stocks To Watch Now – January 31st - Defense World
Big Picture: What are the risks of holding Tyra Biosciences IncMarket Risk Summary & Real-Time Sentiment Analysis - baoquankhu1.vn
Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a Promising 17% Upside Potential in Precision Medicine - DirectorsTalk Interviews
Forecast Cut: Can Tyra Biosciences Inc continue delivering strong returnsWeekly Investment Recap & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Barclays Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $59 - 富途牛牛
Tyra Biosciences stock price target raised to $55 from $35 at Raymond James - Investing.com Canada
Barclays Initiates Coverage of Tyra Biosciences (TYRA) with Overweight Recommendation - Nasdaq
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month HighShould You Buy? - MarketBeat
Tyra Biosciences stock hits all-time high of 31.58 USD - Investing.com
Tyra Biosciences stock hits all-time high of 31.58 USD By Investing.com - Investing.com Nigeria
Technical Analysis: Can Tyra Biosciences Inc continue delivering strong returns2025 Buyback Activity & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Assessing Tyra Biosciences (TYRA) Valuation After Piper Sandler Reaffirms Overweight On Dabogratinib Prospects - Sahm
(TYRA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Promising Growth Stocks To Watch NowJanuary 25th - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Stock Rating Lowered by Wall Street Zen - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Shares Down 5.1%What's Next? - MarketBeat
Tyra Biosciences (TYRA) Stock Report: Biotechnology Innovator with an 8.61% Upside Potential - DirectorsTalk Interviews
Piper Sandler Issues Positive Forecast for Tyra Biosciences (NASDAQ:TYRA) Stock Price - MarketBeat
Piper Sandler raises Tyra Biosciences stock price target to $42 on growth outlook - Investing.com Canada
Tyra Biosciences stock hits 52-week high at 30.85 USD By Investing.com - Investing.com Australia
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year HighHere's Why - MarketBeat
Tyra Biosciences stock hits 52-week high at 30.85 USD - Investing.com
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Tyra Biosciences, Inc. (TYRA): Investor Outlook on a Promising Biotech with 15.68% Upside Potential - DirectorsTalk Interviews
Non-Muscle Invasive Bladder Cancer Pipeline and Clinical Trial - openPR.com
Tyra Biosciences (TYRA) Is Up 9.4% After New COO Hire And 52-Week High Has The Bull Case Changed? - Sahm
Can Tyra Biosciences Inc. stock surprise with earnings upsideJuly 2025 Drop Watch & Technical Entry and Exit Alerts - ulpravda.ru
About Us | Cabling Installation & MaintenanceTyra Biosciences, Inc.Common Stock (Nasdaq:TYRA) Price Chart - FinancialContent
Tyra Biosciences, Inc. (TYRA) Stock Analysis: A Biotech With A Potential 10.61% Upside - DirectorsTalk Interviews
Is Tyra Biosciences Inc. stock a dividend growth opportunity2025 Key Lessons & Weekly High Return Forecasts - Улправда
Tyra Biosciences stock hits 52-week high at $30.27 By Investing.com - Investing.com India
Tyra Biosciences stock hits 52-week high at $30.27 - Investing.com
How Tyra Biosciences Inc. stock reacts to global recession fearsPortfolio Risk Summary & AI Driven Stock Reports - Улправда
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $32 - 富途牛牛
Promising Growth Stocks To Follow Now – January 5th - Defense World
Tyra Biosciences (NASDAQ:TYRA) Shares Down 6%What's Next? - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):